VAMG
EDIT icon

Voisard Asset Management Group’s Editas Medicine EDIT Stock Holding History

Voisard Asset Management Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$341 – 244
2024
Q3 		$341 Hold
100
– – ﹤0.01% 671
2024
Q2 		$467 Hold
100
– – ﹤0.01% 368
2024
Q1 		$742 Hold
100
– – ﹤0.01% 335
2023
Q4 		$1.01K Buy
+100
New +$878 ﹤0.01% 353

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voisard Asset Management Group's EDIT Position: Q4 2024 in Review

Voisard Asset Management Group sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 100 shares — an estimated $341 sold.

Voisard Asset Management Group first reported a position in EDIT in Q4 2023 and held it in 4 quarters. The position peaked at $1.01K in Q4 2023. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Voisard Asset Management Group reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Voisard Asset Management Group sold 100 Editas Medicine shares in Q4 2024, an estimated $341.
  • Voisard Asset Management Group first reported a position in Editas Medicine in Q4 2023 and held it in 4 quarters.
  • Voisard Asset Management Group's Editas Medicine position peaked at $1.01K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Voisard Asset Management Group's 13F filing for Q4 2024, filed 7 Feb 2025.